Bristol-Myers Squibb   4Q Revenues: $5.5 billion (+7%) 4Q Earnings: $852 million (+76%) FY Revenues: $21.2 billion (+9%) FY Earnings: $3.7 billion (+20%) Comments: U.S. sales increased 8% to $3.6 billion in the quarter and International sales increased 4% to $1.9 billion. Plavix sales were $ 1.7 billion in the quarter (-3%). Avapro/Avalide sales were down 23% to $195 million. Abilify sales were $737 million (+4%). Reyataz sales were up 11% to $416 million. Sustiva Franchise sales were $412 m...